High expression of MYO10 contributes to the tumor invasion and migration of breast cancer (Cao et al. 2014), prostate cancer (Makowska et al. 2015), and colorectal cancer (Ou et al. 2022). This evidence concerns the gene MYO10 and prostate carcinoma.